DrugPatentWatch Database Preview
Ptc Therap Company Profile
» See Plans and Pricing
What is the competitive landscape for PTC THERAP, and what generic and branded alternatives to PTC THERAP drugs are available?
PTC THERAP has two approved drugs.
Drugs and US Patents for Ptc Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-004 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-003 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-002 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-004 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-001 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | SUSPENSION;ORAL | 208685-001 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Ptc Therap | EMFLAZA | deflazacort | SUSPENSION;ORAL | 208685-001 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.